Bal Pharma (BOM:524824) OCF Margin %: 0.00% (As of Mar. 2026)


BOM:524824 Bal Pharma Ltd BOM:524824
65 GF Score
Price ₹78.12
GF Value ₹97.35
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bal Pharma OCF Margin %?

Bal Pharma BOM:524824 -0.59% 65 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:524824 with a GF Score™ of 65/100 and a GF Value™ of ₹97.35 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 960 Drug Manufacturers companies, Bal Pharma ranks worse than 50.63% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Bal Pharma's Cash Flow from Operations for the three months ended in Mar. 2026 was ₹0 Mil. Bal Pharma's Revenue for the three months ended in Mar. 2026 was ₹841 Mil. Therefore, Bal Pharma's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Bal Pharma's current OCF Yield % is 24.48%.

The historical rank and industry rank for Bal Pharma's OCF Margin % or its related term are showing as below:

BOM:524824' s OCF Margin % Range Over the Past 10 Years
Min: -0.51   Med: 6.85   Max: 13.86
Current: 9.77

During the past 13 years, the highest OCF Margin % of Bal Pharma was 13.86%. The lowest was -0.51%. And the median was 6.85%.

BOM:524824's OCF Margin % is ranked worse than
50.63% of 960 companies
in the Drug Manufacturers industry
Industry Median: 9.945 vs BOM:524824: 9.77

Bal Pharma OCF Margin % Related Terms

Bal Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Bal Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bal Pharma OCF Margin % Chart

Bal Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.58 -0.51 6.99 6.70 9.77

Bal Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:524824 vs ZTS, UTHR: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bal Pharma OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Bal Pharma's OCF Margin % falls into.


BOM:524824
65GF Score
Bal Pharma Ltd BOM:524824
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bal Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Bal Pharma's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=304.429/3116.613
=9.77 %

Bal Pharma's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/840.757
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Bal Pharma (BOM:524824) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bal Pharma and its competitors. According to the industry distribution chart, Bal Pharma ranks #486 out of 960 companies in the Drug Manufacturers industry, placing it in the top 50.6%.
Is Bal Pharma's OCF Margin % too high?
Bal Pharma's current OCF Margin % is 0.00%. Based on the distribution chart, Bal Pharma ranks #486 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bal Pharma has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bal Pharma's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bal Pharma ranks #486 out of 960 companies for OCF Margin %. This places Bal Pharma in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bal Pharma and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bal Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bal Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bal Pharma (BOM:524824) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹97.35, compared to a current price of ₹78.12 — trading 19.8% below its estimated fair value. The current OCF Margin % is 0.00%. Bal Pharma's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bal Pharma (BOM:524824), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bal Pharma (BOM:524824) Overvalued in 2026?

Based on GuruFocus' analysis, Bal Pharma stock appears to be undervalued. The current stock price of ₹78.12 is trading 19.8% below its estimated GF Value™ of ₹97.35. GuruFocus considers Bal Pharma to be Modestly Undervalued.

Key valuation signals for BOM:524824:

  • OCF Margin %: 0.00%
  • GF Value™: ₹97.35 vs. price of ₹78.12 (19.8% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the BOM:524824 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bal Pharma Business Description

Other Exchanges BALPHARMA:India
Address 10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
65GF Score

Get the complete analysis for BOM:524824

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹78.12
Price
₹97.35
GF Value